Related Experiment Video
Updated: Mar 16, 2026
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.7K
[PINK1 and the related diseases]
1Department of Pediatrics, West China Second University Hospital, Sichuan University/Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Chengdu 610041, China. mudz@scu.edu.cn.
Summary
Phosphatase and tensin homolog deleted on chromosome ten induced kinase 1 (PINK1) is a mitochondrial protein kinase. Research explores its role in Parkinson's disease and other conditions like cancer and diabetes.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Phosphatase and tensin homolog deleted on chromosome ten (PINK1) is a mitochondrial membrane protein kinase.
- PINK1 is implicated in various biological processes, including mitochondrial function, morphology, and autophagy.
- Mutations in PINK1 are linked to autosomal recessive Parkinson's disease.
Purpose of the Study:
- To review recent studies on the biological functions of PINK1.
- To explore the association of PINK1 with various diseases.
- To identify potential therapeutic targets for PINK1-related disorders.
Main Methods:
- Literature review of recent studies on PINK1.
- Analysis of PINK1's role in cellular processes.
- Examination of PINK1's involvement in disease pathogenesis.
Main Results:
- PINK1 localizes to the outer mitochondrial membrane and regulates cellular functions via protein phosphorylation.
- PINK1 exhibits diverse biological activities, particularly in high-energy-demand tissues.
- Emerging evidence links PINK1 to neonatal hypoxic-ischemic encephalopathy, cancer, and diabetes.
Conclusions:
- Understanding PINK1's functions is crucial for elucidating its role in disease.
- PINK1 represents a potential therapeutic target for neurodegenerative and other diseases.
- Further research into PINK1's regulatory pathways and disease associations is warranted.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:33Pleiotropy
43.9K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.9K
01:22Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
01:37Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
01:22PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K